Global Roxatidine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152770
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug.

Scope of the Report:

The worldwide market for Roxatidine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Roxatidine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Sanofi Aventis

Sihuan Pharmaceutical

Sun Pharmaceutical

Taj Pharmaceuticals

Shin Poong Pharmaceuticals

Sawai Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oral

Injectable

Market Segment by Applications, can be divided into

Acidity

Heartburn

Intestinal Ulcers

Stomach Ulcers

Others

There are 15 Chapters to deeply display the global Roxatidine market.

Chapter 1, to describe Roxatidine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Roxatidine, with sales, revenue, and price of Roxatidine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Roxatidine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Roxatidine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Roxatidine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Roxatidine Introduction

1.2 Market Analysis by Type

1.2.1 Oral

1.2.2 Injectable

1.3 Market Analysis by Applications

1.3.1 Acidity

1.3.2 Heartburn

1.3.3 Intestinal Ulcers

1.3.4 Stomach Ulcers

1.3.5 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Sanofi Aventis

2.1.1 Business Overview

2.1.2 Roxatidine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Aventis Roxatidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sihuan Pharmaceutical

2.2.1 Business Overview

2.2.2 Roxatidine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sihuan Pharmaceutical Roxatidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sun Pharmaceutical

2.3.1 Business Overview

2.3.2 Roxatidine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sun Pharmaceutical Roxatidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Taj Pharmaceuticals

2.4.1 Business Overview

2.4.2 Roxatidine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Taj Pharmaceuticals Roxatidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Shin Poong Pharmaceuticals

2.5.1 Business Overview

2.5.2 Roxatidine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Shin Poong Pharmaceuticals Roxatidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sawai Pharmaceutical

2.6.1 Business Overview

2.6.2 Roxatidine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sawai Pharmaceutical Roxatidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Roxatidine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Roxatidine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Roxatidine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Roxatidine Manufacturer Market Share in 2017

3.3.2 Top 6 Roxatidine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Roxatidine Market Analysis by Regions

4.1 Global Roxatidine Sales, Revenue and Market Share by Regions

4.1.1 Global Roxatidine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Roxatidine Revenue and Market Share by Regions (2013-2018)

4.2 North America Roxatidine Sales and Growth Rate (2013-2018)

4.3 Europe Roxatidine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Roxatidine Sales and Growth Rate (2013-2018)

4.5 South America Roxatidine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Roxatidine Sales and Growth Rate (2013-2018)

5 North America Roxatidine by Countries

5.1 North America Roxatidine Sales, Revenue and Market Share by Countries

5.1.1 North America Roxatidine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Roxatidine Revenue and Market Share by Countries (2013-2018)

5.2 United States Roxatidine Sales and Growth Rate (2013-2018)

5.3 Canada Roxatidine Sales and Growth Rate (2013-2018)

5.4 Mexico Roxatidine Sales and Growth Rate (2013-2018)

6 Europe Roxatidine by Countries

6.1 Europe Roxatidine Sales, Revenue and Market Share by Countries

6.1.1 Europe Roxatidine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Roxatidine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Roxatidine Sales and Growth Rate (2013-2018)

6.3 UK Roxatidine Sales and Growth Rate (2013-2018)

6.4 France Roxatidine Sales and Growth Rate (2013-2018)

6.5 Russia Roxatidine Sales and Growth Rate (2013-2018)

6.6 Italy Roxatidine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Roxatidine by Countries

7.1 Asia-Pacific Roxatidine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Roxatidine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Roxatidine Revenue and Market Share by Countries (2013-2018)

7.2 China Roxatidine Sales and Growth Rate (2013-2018)

7.3 Japan Roxatidine Sales and Growth Rate (2013-2018)

7.4 Korea Roxatidine Sales and Growth Rate (2013-2018)

7.5 India Roxatidine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Roxatidine Sales and Growth Rate (2013-2018)

8 South America Roxatidine by Countries

8.1 South America Roxatidine Sales, Revenue and Market Share by Countries

8.1.1 South America Roxatidine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Roxatidine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Roxatidine Sales and Growth Rate (2013-2018)

8.3 Argentina Roxatidine Sales and Growth Rate (2013-2018)

8.4 Colombia Roxatidine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Roxatidine by Countries

9.1 Middle East and Africa Roxatidine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Roxatidine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Roxatidine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Roxatidine Sales and Growth Rate (2013-2018)

9.3 UAE Roxatidine Sales and Growth Rate (2013-2018)

9.4 Egypt Roxatidine Sales and Growth Rate (2013-2018)

9.5 Nigeria Roxatidine Sales and Growth Rate (2013-2018)

9.6 South Africa Roxatidine Sales and Growth Rate (2013-2018)

10 Global Roxatidine Market Segment by Type

10.1 Global Roxatidine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Roxatidine Sales and Market Share by Type (2013-2018)

10.1.2 Global Roxatidine Revenue and Market Share by Type (2013-2018)

10.2 Oral Sales Growth and Price

10.2.1 Global Oral Sales Growth (2013-2018)

10.2.2 Global Oral Price (2013-2018)

10.3 Injectable Sales Growth and Price

10.3.1 Global Injectable Sales Growth (2013-2018)

10.3.2 Global Injectable Price (2013-2018)

11 Global Roxatidine Market Segment by Application

11.1 Global Roxatidine Sales Market Share by Application (2013-2018)

11.2 Acidity Sales Growth (2013-2018)

11.3 Heartburn Sales Growth (2013-2018)

11.4 Intestinal Ulcers Sales Growth (2013-2018)

11.5 Stomach Ulcers Sales Growth (2013-2018)

11.6 Others Sales Growth (2013-2018)

12 Roxatidine Market Forecast (2018-2023)

12.1 Global Roxatidine Sales, Revenue and Growth Rate (2018-2023)

12.2 Roxatidine Market Forecast by Regions (2018-2023)

12.2.1 North America Roxatidine Market Forecast (2018-2023)

12.2.2 Europe Roxatidine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Roxatidine Market Forecast (2018-2023)

12.2.4 South America Roxatidine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Roxatidine Market Forecast (2018-2023)

12.3 Roxatidine Market Forecast by Type (2018-2023)

12.3.1 Global Roxatidine Sales Forecast by Type (2018-2023)

12.3.2 Global Roxatidine Market Share Forecast by Type (2018-2023)

12.4 Roxatidine Market Forecast by Application (2018-2023)

12.4.1 Global Roxatidine Sales Forecast by Application (2018-2023)

12.4.2 Global Roxatidine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Roxatidine Picture

Table Product Specifications of Roxatidine

Figure Global Sales Market Share of Roxatidine by Types in 2017

Table Roxatidine Types for

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery